Tag: coronary artery disease market share

  • Laser Atherectomy Devices Market Size Growth: From $1.41 Billion In 2026 To $1.98 Billion By 2030

    Laser Atherectomy Devices Market Size Growth: From $1.41 Billion In 2026 To $1.98 Billion By 2030

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    #Laser Atherectomy Devices Market Size Forecast: How Big Could The Market Get By 2030?#_x000D_

    The laser atherectomy devices market size has demonstrated robust expansion over recent years. It is anticipated to increase from $1.3 billion in 2025 to $1.41 billion in 2026, at a compound annual growth rate (CAGR) of 8.7%. This historical growth can be attributed to the rising prevalence of peripheral artery disease, an increasing incidence of cardiovascular disorders, the expansion of catheter-based interventions, the availability of advanced laser technologies, and the growth of interventional cardiology centers._x000D_

    _x000D_

    The laser atherectomy devices market size is anticipated to experience substantial expansion over the upcoming years. Its value is projected to reach $1.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is driven by several factors, including the increasing need for minimally invasive vascular treatments, a greater uptake of image-guided interventions, the expansion of cardiovascular procedures performed in outpatient settings, ongoing technological advancements in laser systems, and an intensifying focus on lowering restenosis rates. Key trends expected in the forecast period encompass a rising embrace of laser-based plaque removal methods, increased utilization of computer-controlled atherectomy systems, an expanding demand for minimally invasive vascular interventions, broader application in peripheral and neurovascular fields, and an elevated emphasis on precision and safety in procedures._x000D_

    _x000D_

    #Get A Free Sample Report With In-Depth Market Insights:#_x000D_

    https://thebusinessresearchcompany.com/sample_request?id=20493014&type=smp&name=Laser%20Atherectomy%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

    _x000D_

    #Laser Atherectomy Devices Market Growth Factors Behind Sustained Expansion#_x000D_

    The increasing prevalence of cardiovascular diseases is projected to stimulate the expansion of the laser atherectomy devices market in the future. Cardiovascular disease (CVD) encompasses various conditions impacting the heart or blood vessels, frequently affecting the body’s circulatory system. An uptick in cardiovascular diseases leads to a larger patient population needing interventions for arterial blockages and atherosclerotic plaque, consequently generating increased demand for laser atherectomy devices. As an illustration, in January 2024, data from the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. This demonstrates that the rise in cardiovascular diseases is indeed fueling the growth of the laser atherectomy devices market._x000D_

    _x000D_

    #Laser Atherectomy Devices Market Segment Analysis And Revenue Potential#_x000D_

    The laser atherectomy devices market covered in this report is segmented – _x000D_

    _x000D_

    1) By Type: Excimer Laser Atherectomy Devices, Solid-State Laser Atherectomy Devices, Ultraviolet (UV) Laser Atherectomy Devices, Infrared (IR) Laser Atherectomy Devices_x000D_

    2) By Application: Cardiovascular, Peripheral Vascular, Neurovascular_x000D_

    3) By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems, Peripheral Excimer Laser Systems, In-Stent Restenosis (ISR) Laser Systems_x000D_

    2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems, Holmium:YAG Laser Atherectomy Systems, Diode-Based Laser Atherectomy Systems_x000D_

    3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems, Continuous-Wave UV Laser Atherectomy Systems_x000D_

    4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems, Mid-Infrared Laser Atherectomy Systems_x000D_

    _x000D_

    #Laser Atherectomy Devices Market Industry Trends Fueling Future Revenue Growth#_x000D_

    Leading companies in the laser atherectomy devices market are developing advanced solutions, such as atherectomy platforms, to cater to broader customer bases, increase sales, and boost revenue. An atherectomy platform refers to a comprehensive system or array of tools designed for treating atherosclerosis, a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced that its FreedomFlow, an orbital atherectomy peripheral platform, received clearance from the United States Food and Drug Administration (FDA). The distinctiveness of the FreedomFlow platform lies in its modern mechanism of action, specifically engineered for clearing plaque blockages in leg arteries. This proprietary, catheter-based design leverages angular momentum physics to create a spiral geometry, ensuring simultaneous contact with the vessel wall during both advancement and retraction via five diamond-coated spheres. Additionally, a diamond-coated tip aids the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable method for treating complex Peripheral Artery Disease (PAD) across a wide range of vessel diameters, from 2 mm in the ankle to 8 mm in the hip. The platform offers enhanced versatility in tackling multiple arteries and numerous blockages within the same vessel, all using a single device._x000D_

    _x000D_

    #Laser Atherectomy Devices Market Competitive Landscape: Who Leads The Industry?#_x000D_

    Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc _x000D_

    _x000D_

    #View The Full Laser Atherectomy Devices Market Report:#_x000D_

    https://thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

    _x000D_

    #Laser Atherectomy Devices Market Geographic Landscape: Which Region Dominates Industry Growth?#_x000D_

    North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #Reach Out To Our Team:#_x000D_

    _x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas: +1 310-496-7795_x000D_

    Asia: +44 7882 955267 & +91 8897263534_x000D_

    Europe: +44 7882 955267_x000D_

    Email us at: marketing@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Coronary Artery Disease Market Future Analysis Covering Industry Shifts And Growth Potential

    Coronary Artery Disease Market Future Analysis Covering Industry Shifts And Growth Potential

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Estimated Growth In Market Size Of The Coronary Artery Disease Market During 2026–2030?

    The coronary artery disease market has experienced swift expansion in its scale over recent years. It is anticipated to increase from $31.88 billion in 2025 to $35.27 billion in 2026, with a compound annual growth rate (CAGR) of 10.6%. The historical surge can be linked to the significant occurrence of cardiovascular disease, the adoption of sedentary lifestyles, tobacco consumption, insufficient knowledge about preventive care, and treatment approaches primarily based in hospitals.

    The coronary artery disease market size is poised for substantial expansion in the coming years. Its valuation is projected to reach $53.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.2%. This anticipated growth during the forecast period is propelled by factors such as an aging global population, increasing obesity rates, advancements in diagnostic technologies, the proliferation of preventive cardiology initiatives, and enhanced healthcare accessibility. Key developments anticipated within this period involve a heightened emphasis on early disease detection, an uptick in the utilization of combination drug therapies, the expansion of lifestyle modification programs, a greater adoption of minimally invasive treatments, and the integration of cardiac rehabilitation services.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

    What Key Growth Drivers Are Influencing The Coronary Artery Disease Market?

    The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market in the upcoming years. Coronary artery disease (CAD) is a health condition defined by the constriction or obstruction of the coronary arteries, which are responsible for delivering blood to the heart muscle. The number of coronary artery disease cases is growing, attributed to evolving dietary habits, elevated stress levels, insufficient physical activity, obesity, aging, and other factors. Treatment for coronary artery disease involves medications like clopidogrel, ticagrelor, warfarin, and heparin, alongside procedures such as coronary artery bypass grafting, angioplasty, and stenting. For example, data published in October 2025 by the Australian Institute of Health and Welfare, an Australian government body, indicated that in 2023, approximately 2,700 acute coronary events affected First Nations individuals aged 25 and above. When age-adjusted, this rate was 2.8 times higher compared to non-Indigenous populations. Consequently, the expanding prevalence of coronary artery disease is anticipated to stimulate the coronary artery disease market throughout the forecast period.

    Which Segment Groups Define The Coronary Artery Disease Market Landscape?

    The coronary artery disease market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

    2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    4) By End-User: Hospitals, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

    2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

    3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

    4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

    What Trends Are Shaping The Coronary Artery Disease Market Structure?

    Companies operating in the coronary artery disease market are concentrating on developing innovative products, such as drug-coated balloon catheters, to enhance market revenues. Drug-coated balloon catheters are medical devices employed in interventional cardiology to treat narrowed or blocked blood vessels, specifically in the context of coronary artery disease or peripheral artery disease. For example, in March 2024, Boston Scientific Corporation, a medical device company based in the US, announced that its AGENT Drug-Coated Balloon (DCB) received US Food and Drug Administration (FDA) approval. This device is indicated for managing coronary in-stent restenosis (ISR) in patients suffering from coronary artery disease. In-stent restenosis is characterized by the obstruction or narrowing of a stented vessel due to plaque or scar tissue. The AGENT DCB provides a specialized treatment solution for the challenging condition of in-stent restenosis (ISR), addressing a significant unmet medical need. It is specifically designed to treat ISR as well as previously untreated small vessel coronary disease. Available across Europe, various parts of Asia Pacific, and Latin America, the AGENT DCB offers a targeted approach for these complex cardiovascular conditions.

    Which Companies Are Influencing The Coronary Artery Disease Market?

    Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

    Access The Complete Coronary Artery Disease Market Report:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Region Stands As The Largest Contributor To The Coronary Artery Disease Market?

    North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Coronary Artery Disease Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

    Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

    Coronary Artery Disease Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Aortic Stent Grafts Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report

    Heart Transplant Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Is The Expected Market Size Of The Laser Atherectomy Devices Market In 2026 And How Much Will It Reach By 2030?

    The laser atherectomy devices market has witnessed robust expansion in recent years. Its valuation is anticipated to rise from $1.3 billion in 2025 to $1.41 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.7%. Key drivers contributing to this past growth include the escalating prevalence of peripheral artery disease, a higher incidence of cardiovascular disorders, the expansion of catheter-based interventions, the availability of sophisticated laser technologies, and the proliferation of interventional cardiology centers.

    The laser atherectomy devices market size is anticipated to experience robust expansion over the forthcoming years. It is projected to reach $1.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth throughout the forecast period stems from factors such as increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, and a growing focus on reducing restenosis rates. Prominent trends for the forecast period include the increasing adoption of laser-based plaque removal techniques, the rising use of computer-controlled atherectomy systems, a growing demand for minimally invasive vascular interventions, the expansion of peripheral and neurovascular applications, and an enhanced focus on precision and procedural safety.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10600&type=smp

    What Major Growth Factors Are Impacting The Laser Atherectomy Devices Market?

    The increasing prevalence of cardiovascular diseases is expected to propel the growth of the laser atherectomy devices market in the future. Cardiovascular disease (CVD) refers to a category of ailments involving the heart or blood vessels, typically impacting the circulatory system. A surge in cardiovascular diseases leads to an expanded patient pool requiring treatment for arterial blockages and atherosclerotic plaque, thereby generating increased demand for laser atherectomy devices. For example, in January 2024, the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, representing an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is a significant factor driving the expansion of the laser atherectomy devices market.

    How Does Segment Analysis Break Down The Laser Atherectomy Devices Market Structure?

    The laser atherectomy devices market covered in this report is segmented –

    1) By Type: Excimer Laser Atherectomy Devices, Solid-State Laser Atherectomy Devices, Ultraviolet (UV) Laser Atherectomy Devices, Infrared (IR) Laser Atherectomy Devices

    2) By Application: Cardiovascular, Peripheral Vascular, Neurovascular

    3) By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users

    Subsegments:

    1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems, Peripheral Excimer Laser Systems, In-Stent Restenosis (ISR) Laser Systems

    2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems, Holmium:YAG Laser Atherectomy Systems, Diode-Based Laser Atherectomy Systems

    3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems, Continuous-Wave UV Laser Atherectomy Systems

    4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems, Mid-Infrared Laser Atherectomy Systems

    What Trends Are Impacting The Laser Atherectomy Devices Market?

    Leading companies in the laser atherectomy devices market are developing advanced solutions, such as atherectomy platforms, to reach larger customer bases, increase sales, and boost revenue. An atherectomy platform is a comprehensive system or set of tools designed for the treatment of atherosclerosis, a medical condition marked by the buildup of plaque in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance for its FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform is its contemporary mechanism of action, specifically tailored for clearing plaque blockages in leg arteries. This exclusive, catheter-based design employs angular momentum physics, creating a spiral geometry that, with the inclusion of five diamond-coated spheres, ensures simultaneous contact with the vessel wall during both advancement and retraction. Additionally, a diamond-coated tip aids the smooth passage of the driveshaft through narrow blockages. This novel approach furnishes physicians with an exceptionally efficient, effective, and adaptable method for treating complex Peripheral Artery Disease (PAD) across a wide spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform provides enhanced versatility in addressing multiple arteries and numerous blockages within the same vessel, all accomplished with a single device.

    Who Are The Prominent Players Across The Laser Atherectomy Devices Market?

    Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc

    Access The Complete Laser Atherectomy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Which Region Has The Strongest Presence In The Laser Atherectomy Devices Market?

    North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Laser Atherectomy Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Browse Through More Reports Similar to the Global Laser Atherectomy Devices Market 2026, By The Business Research Company

    Atherectomy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

    Ophthalmic Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ophthalmic-medical-lasers-global-market-report

    Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-lasers-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Is The Expected Market Size Of The Laser Atherectomy Devices Market In 2026 And How Much Will It Reach By 2030?

    The laser atherectomy devices market has witnessed robust expansion in recent years. Its valuation is anticipated to rise from $1.3 billion in 2025 to $1.41 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.7%. Key drivers contributing to this past growth include the escalating prevalence of peripheral artery disease, a higher incidence of cardiovascular disorders, the expansion of catheter-based interventions, the availability of sophisticated laser technologies, and the proliferation of interventional cardiology centers.

    The laser atherectomy devices market size is anticipated to experience robust expansion over the forthcoming years. It is projected to reach $1.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth throughout the forecast period stems from factors such as increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, and a growing focus on reducing restenosis rates. Prominent trends for the forecast period include the increasing adoption of laser-based plaque removal techniques, the rising use of computer-controlled atherectomy systems, a growing demand for minimally invasive vascular interventions, the expansion of peripheral and neurovascular applications, and an enhanced focus on precision and procedural safety.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10600&type=smp

    What Major Growth Factors Are Impacting The Laser Atherectomy Devices Market?

    The increasing prevalence of cardiovascular diseases is expected to propel the growth of the laser atherectomy devices market in the future. Cardiovascular disease (CVD) refers to a category of ailments involving the heart or blood vessels, typically impacting the circulatory system. A surge in cardiovascular diseases leads to an expanded patient pool requiring treatment for arterial blockages and atherosclerotic plaque, thereby generating increased demand for laser atherectomy devices. For example, in January 2024, the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, representing an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is a significant factor driving the expansion of the laser atherectomy devices market.

    How Does Segment Analysis Break Down The Laser Atherectomy Devices Market Structure?

    The laser atherectomy devices market covered in this report is segmented –

    1) By Type: Excimer Laser Atherectomy Devices, Solid-State Laser Atherectomy Devices, Ultraviolet (UV) Laser Atherectomy Devices, Infrared (IR) Laser Atherectomy Devices

    2) By Application: Cardiovascular, Peripheral Vascular, Neurovascular

    3) By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users

    Subsegments:

    1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems, Peripheral Excimer Laser Systems, In-Stent Restenosis (ISR) Laser Systems

    2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems, Holmium:YAG Laser Atherectomy Systems, Diode-Based Laser Atherectomy Systems

    3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems, Continuous-Wave UV Laser Atherectomy Systems

    4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems, Mid-Infrared Laser Atherectomy Systems

    What Trends Are Impacting The Laser Atherectomy Devices Market?

    Leading companies in the laser atherectomy devices market are developing advanced solutions, such as atherectomy platforms, to reach larger customer bases, increase sales, and boost revenue. An atherectomy platform is a comprehensive system or set of tools designed for the treatment of atherosclerosis, a medical condition marked by the buildup of plaque in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance for its FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform is its contemporary mechanism of action, specifically tailored for clearing plaque blockages in leg arteries. This exclusive, catheter-based design employs angular momentum physics, creating a spiral geometry that, with the inclusion of five diamond-coated spheres, ensures simultaneous contact with the vessel wall during both advancement and retraction. Additionally, a diamond-coated tip aids the smooth passage of the driveshaft through narrow blockages. This novel approach furnishes physicians with an exceptionally efficient, effective, and adaptable method for treating complex Peripheral Artery Disease (PAD) across a wide spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform provides enhanced versatility in addressing multiple arteries and numerous blockages within the same vessel, all accomplished with a single device.

    Who Are The Prominent Players Across The Laser Atherectomy Devices Market?

    Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc

    Access The Complete Laser Atherectomy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Which Region Has The Strongest Presence In The Laser Atherectomy Devices Market?

    North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Laser Atherectomy Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Browse Through More Reports Similar to the Global Laser Atherectomy Devices Market 2026, By The Business Research Company

    Atherectomy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

    Ophthalmic Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ophthalmic-medical-lasers-global-market-report

    Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-lasers-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    Laser Atherectomy Devices Market Expansion Outlook Through 2030 With Revenue Growth Insights

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Is The Expected Market Size Of The Laser Atherectomy Devices Market In 2026 And How Much Will It Reach By 2030?

    The laser atherectomy devices market has witnessed robust expansion in recent years. Its valuation is anticipated to rise from $1.3 billion in 2025 to $1.41 billion in 2026, progressing at a compound annual growth rate (CAGR) of 8.7%. Key drivers contributing to this past growth include the escalating prevalence of peripheral artery disease, a higher incidence of cardiovascular disorders, the expansion of catheter-based interventions, the availability of sophisticated laser technologies, and the proliferation of interventional cardiology centers.

    The laser atherectomy devices market size is anticipated to experience robust expansion over the forthcoming years. It is projected to reach $1.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth throughout the forecast period stems from factors such as increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, and a growing focus on reducing restenosis rates. Prominent trends for the forecast period include the increasing adoption of laser-based plaque removal techniques, the rising use of computer-controlled atherectomy systems, a growing demand for minimally invasive vascular interventions, the expansion of peripheral and neurovascular applications, and an enhanced focus on precision and procedural safety.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10600&type=smp

    What Major Growth Factors Are Impacting The Laser Atherectomy Devices Market?

    The increasing prevalence of cardiovascular diseases is expected to propel the growth of the laser atherectomy devices market in the future. Cardiovascular disease (CVD) refers to a category of ailments involving the heart or blood vessels, typically impacting the circulatory system. A surge in cardiovascular diseases leads to an expanded patient pool requiring treatment for arterial blockages and atherosclerotic plaque, thereby generating increased demand for laser atherectomy devices. For example, in January 2024, the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate attributed to cardiovascular disease rose to 233.3 per 100,000 in 2024, representing an increase of 4.0% from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is a significant factor driving the expansion of the laser atherectomy devices market.

    How Does Segment Analysis Break Down The Laser Atherectomy Devices Market Structure?

    The laser atherectomy devices market covered in this report is segmented –

    1) By Type: Excimer Laser Atherectomy Devices, Solid-State Laser Atherectomy Devices, Ultraviolet (UV) Laser Atherectomy Devices, Infrared (IR) Laser Atherectomy Devices

    2) By Application: Cardiovascular, Peripheral Vascular, Neurovascular

    3) By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users

    Subsegments:

    1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems, Peripheral Excimer Laser Systems, In-Stent Restenosis (ISR) Laser Systems

    2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems, Holmium:YAG Laser Atherectomy Systems, Diode-Based Laser Atherectomy Systems

    3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems, Continuous-Wave UV Laser Atherectomy Systems

    4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems, Mid-Infrared Laser Atherectomy Systems

    What Trends Are Impacting The Laser Atherectomy Devices Market?

    Leading companies in the laser atherectomy devices market are developing advanced solutions, such as atherectomy platforms, to reach larger customer bases, increase sales, and boost revenue. An atherectomy platform is a comprehensive system or set of tools designed for the treatment of atherosclerosis, a medical condition marked by the buildup of plaque in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance for its FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform is its contemporary mechanism of action, specifically tailored for clearing plaque blockages in leg arteries. This exclusive, catheter-based design employs angular momentum physics, creating a spiral geometry that, with the inclusion of five diamond-coated spheres, ensures simultaneous contact with the vessel wall during both advancement and retraction. Additionally, a diamond-coated tip aids the smooth passage of the driveshaft through narrow blockages. This novel approach furnishes physicians with an exceptionally efficient, effective, and adaptable method for treating complex Peripheral Artery Disease (PAD) across a wide spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform provides enhanced versatility in addressing multiple arteries and numerous blockages within the same vessel, all accomplished with a single device.

    Who Are The Prominent Players Across The Laser Atherectomy Devices Market?

    Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc

    Access The Complete Laser Atherectomy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Which Region Has The Strongest Presence In The Laser Atherectomy Devices Market?

    North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Laser Atherectomy Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Browse Through More Reports Similar to the Global Laser Atherectomy Devices Market 2026, By The Business Research Company

    Atherectomy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

    Ophthalmic Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ophthalmic-medical-lasers-global-market-report

    Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-lasers-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Forecasted Market Size Trajectory Of The Coronary Artery Disease Market From 2026 To 2030?

    The coronary artery disease market has experienced rapid growth in recent years. Its value is projected to rise from $31.88 billion in 2025 to $35.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the past can be attributed to elements such as the widespread occurrence of cardiovascular disease, sedentary lifestyles, tobacco consumption, insufficient understanding of preventive care, and healthcare models centered around hospitals.

    The coronary artery disease market is anticipated to experience substantial growth in the upcoming years, projected to reach $53.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period is primarily driven by factors such as the aging global population, increasing obesity rates, advancements in diagnostic technologies, the growth of preventive cardiology, and improved healthcare access. Significant trends expected during this period include a heightened focus on early disease detection, the rising application of combination drug therapies, the development of lifestyle modification programs, an expansion of minimally invasive treatments, and the integration of cardiac rehabilitation services.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Major Drivers Are Influencing The Expansion Of The Coronary Artery Disease Market?

    The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market over the forthcoming years. Coronary artery disease (CAD) refers to a medical condition characterized by the constricting or blocking of the coronary arteries, which are responsible for supplying blood to the heart muscle. Cases of coronary artery disease are escalating due to evolving dietary patterns, heightened stress levels, inadequate exercise, obesity, aging, and other contributing factors. Coronary artery disease is managed with pharmaceuticals such as clopidogrel, ticagrelor, warfarin, and heparin, and through procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, in October 2025, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, an estimated 2,700 acute coronary events occurred among First Nations people aged 25 and older. When accounting for the population’s age structure, the frequency of these events was 2.8 times higher than what was observed in non-Indigenous people. Therefore, the rise in the prevalence of coronary artery disease is anticipated to boost the coronary artery disease market during the forecast period.

    What Are The Key Segment Divisions In The Coronary Artery Disease Market Segment Structure?

    The coronary artery disease market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

    2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    4) By End-User: Hospitals, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

    2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

    3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

    4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

    Which Trends Are Shaping The Coronary Artery Disease Market?

    Leading firms in the coronary artery disease market are concentrating on creating novel products, like drug-coated balloon catheters, to boost their earnings within the market. These drug-coated balloon catheters represent medical devices utilized in interventional cardiology to address constricted or obstructed blood vessels, specifically for coronary artery disease or peripheral artery disease. As an example, in March 2024, Boston Scientific Corporation, a US-based medical device manufacturer, revealed that the US Food and Drug Administration (FDA) had approved its AGENT Drug-Coated Balloon (DCB), designed for treating coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR refers to the blockage or tightening of a stented blood vessel due to plaque or scar tissue formation. The AGENT DCB presents a specialized treatment alternative for the difficult issue of in-stent restenosis (ISR), thereby fulfilling a crucial unmet medical requirement. Its design specifically targets the treatment of ISR and also addresses previously unmanaged small vessel coronary disease. Currently accessible in Europe, certain regions of Asia Pacific, and Latin America, the AGENT DCB delivers a focused remedy for these intricate cardiovascular ailments.

    Which Organizations Are Engaged In The Coronary Artery Disease Market?

    Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

    Get The Full Coronary Artery Disease Market Report:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Region Is The Leading Market For The Coronary Artery Disease Market?

    North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Coronary Artery Disease Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

    Coronary Pressure Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-pressure-global-market-report

    Acute Coronary Syndrome Market Report 2026

    https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

    Coronary Stents Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Forecasted Market Size Trajectory Of The Coronary Artery Disease Market From 2026 To 2030?

    The coronary artery disease market has experienced rapid growth in recent years. Its value is projected to rise from $31.88 billion in 2025 to $35.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the past can be attributed to elements such as the widespread occurrence of cardiovascular disease, sedentary lifestyles, tobacco consumption, insufficient understanding of preventive care, and healthcare models centered around hospitals.

    The coronary artery disease market is anticipated to experience substantial growth in the upcoming years, projected to reach $53.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period is primarily driven by factors such as the aging global population, increasing obesity rates, advancements in diagnostic technologies, the growth of preventive cardiology, and improved healthcare access. Significant trends expected during this period include a heightened focus on early disease detection, the rising application of combination drug therapies, the development of lifestyle modification programs, an expansion of minimally invasive treatments, and the integration of cardiac rehabilitation services.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Major Drivers Are Influencing The Expansion Of The Coronary Artery Disease Market?

    The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market over the forthcoming years. Coronary artery disease (CAD) refers to a medical condition characterized by the constricting or blocking of the coronary arteries, which are responsible for supplying blood to the heart muscle. Cases of coronary artery disease are escalating due to evolving dietary patterns, heightened stress levels, inadequate exercise, obesity, aging, and other contributing factors. Coronary artery disease is managed with pharmaceuticals such as clopidogrel, ticagrelor, warfarin, and heparin, and through procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, in October 2025, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, an estimated 2,700 acute coronary events occurred among First Nations people aged 25 and older. When accounting for the population’s age structure, the frequency of these events was 2.8 times higher than what was observed in non-Indigenous people. Therefore, the rise in the prevalence of coronary artery disease is anticipated to boost the coronary artery disease market during the forecast period.

    What Are The Key Segment Divisions In The Coronary Artery Disease Market Segment Structure?

    The coronary artery disease market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

    2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    4) By End-User: Hospitals, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

    2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

    3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

    4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

    Which Trends Are Shaping The Coronary Artery Disease Market?

    Leading firms in the coronary artery disease market are concentrating on creating novel products, like drug-coated balloon catheters, to boost their earnings within the market. These drug-coated balloon catheters represent medical devices utilized in interventional cardiology to address constricted or obstructed blood vessels, specifically for coronary artery disease or peripheral artery disease. As an example, in March 2024, Boston Scientific Corporation, a US-based medical device manufacturer, revealed that the US Food and Drug Administration (FDA) had approved its AGENT Drug-Coated Balloon (DCB), designed for treating coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR refers to the blockage or tightening of a stented blood vessel due to plaque or scar tissue formation. The AGENT DCB presents a specialized treatment alternative for the difficult issue of in-stent restenosis (ISR), thereby fulfilling a crucial unmet medical requirement. Its design specifically targets the treatment of ISR and also addresses previously unmanaged small vessel coronary disease. Currently accessible in Europe, certain regions of Asia Pacific, and Latin America, the AGENT DCB delivers a focused remedy for these intricate cardiovascular ailments.

    Which Organizations Are Engaged In The Coronary Artery Disease Market?

    Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

    Get The Full Coronary Artery Disease Market Report:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Region Is The Leading Market For The Coronary Artery Disease Market?

    North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Coronary Artery Disease Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

    Coronary Pressure Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-pressure-global-market-report

    Acute Coronary Syndrome Market Report 2026

    https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

    Coronary Stents Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    Increasing coronary artery disease cases are driving expansion in the coronary artery disease market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Forecasted Market Size Trajectory Of The Coronary Artery Disease Market From 2026 To 2030?

    The coronary artery disease market has experienced rapid growth in recent years. Its value is projected to rise from $31.88 billion in 2025 to $35.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the past can be attributed to elements such as the widespread occurrence of cardiovascular disease, sedentary lifestyles, tobacco consumption, insufficient understanding of preventive care, and healthcare models centered around hospitals.

    The coronary artery disease market is anticipated to experience substantial growth in the upcoming years, projected to reach $53.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period is primarily driven by factors such as the aging global population, increasing obesity rates, advancements in diagnostic technologies, the growth of preventive cardiology, and improved healthcare access. Significant trends expected during this period include a heightened focus on early disease detection, the rising application of combination drug therapies, the development of lifestyle modification programs, an expansion of minimally invasive treatments, and the integration of cardiac rehabilitation services.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Major Drivers Are Influencing The Expansion Of The Coronary Artery Disease Market?

    The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market over the forthcoming years. Coronary artery disease (CAD) refers to a medical condition characterized by the constricting or blocking of the coronary arteries, which are responsible for supplying blood to the heart muscle. Cases of coronary artery disease are escalating due to evolving dietary patterns, heightened stress levels, inadequate exercise, obesity, aging, and other contributing factors. Coronary artery disease is managed with pharmaceuticals such as clopidogrel, ticagrelor, warfarin, and heparin, and through procedures like coronary artery bypass grafting, angioplasty, and stenting. For example, in October 2025, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, an estimated 2,700 acute coronary events occurred among First Nations people aged 25 and older. When accounting for the population’s age structure, the frequency of these events was 2.8 times higher than what was observed in non-Indigenous people. Therefore, the rise in the prevalence of coronary artery disease is anticipated to boost the coronary artery disease market during the forecast period.

    What Are The Key Segment Divisions In The Coronary Artery Disease Market Segment Structure?

    The coronary artery disease market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

    2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    4) By End-User: Hospitals, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

    2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

    3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

    4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

    Which Trends Are Shaping The Coronary Artery Disease Market?

    Leading firms in the coronary artery disease market are concentrating on creating novel products, like drug-coated balloon catheters, to boost their earnings within the market. These drug-coated balloon catheters represent medical devices utilized in interventional cardiology to address constricted or obstructed blood vessels, specifically for coronary artery disease or peripheral artery disease. As an example, in March 2024, Boston Scientific Corporation, a US-based medical device manufacturer, revealed that the US Food and Drug Administration (FDA) had approved its AGENT Drug-Coated Balloon (DCB), designed for treating coronary in-stent restenosis (ISR) in individuals with coronary artery disease. ISR refers to the blockage or tightening of a stented blood vessel due to plaque or scar tissue formation. The AGENT DCB presents a specialized treatment alternative for the difficult issue of in-stent restenosis (ISR), thereby fulfilling a crucial unmet medical requirement. Its design specifically targets the treatment of ISR and also addresses previously unmanaged small vessel coronary disease. Currently accessible in Europe, certain regions of Asia Pacific, and Latin America, the AGENT DCB delivers a focused remedy for these intricate cardiovascular ailments.

    Which Organizations Are Engaged In The Coronary Artery Disease Market?

    Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

    Get The Full Coronary Artery Disease Market Report:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Which Region Is The Leading Market For The Coronary Artery Disease Market?

    North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Coronary Artery Disease Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

    Coronary Pressure Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-pressure-global-market-report

    Acute Coronary Syndrome Market Report 2026

    https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

    Coronary Stents Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Laser Atherectomy Devices Market Developments And Opportunities Across 2026–2030

    Laser Atherectomy Devices Market Developments And Opportunities Across 2026–2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Laser Atherectomy Devices Market Expected To Reach Based On Its 2026 Value?

    The laser atherectomy devices market size has seen strong growth in recent years. It is projected to increase from $1.3 billion in 2025 to $1.41 billion in 2026, with a compound annual growth rate (CAGR) of 8.7%. This historical growth can be attributed to the rising prevalence of peripheral artery disease, the increasing incidence of cardiovascular disorders, the expansion of catheter-based interventions, the availability of advanced laser technologies, and the growth of interventional cardiology centers.

    The laser atherectomy devices market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $1.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the forecast timeframe include the rising need for less invasive vascular therapies, the increasing use of image-guided procedures, the expansion of cardiovascular procedures performed in outpatient settings, ongoing technological progress in laser systems, and a heightened emphasis on lowering restenosis rates. Key developments expected over the forecast period encompass a greater embrace of laser-driven plaque removal methods, the increasing deployment of computer-controlled atherectomy systems, an expanding requirement for minimally invasive vascular operations, the broadening scope of peripheral and neurovascular applications, and a stronger commitment to procedural accuracy and patient safety.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Which Drivers Are Supporting The Laser Atherectomy Devices Market Growth?

    The laser atherectomy devices market is anticipated to expand as a result of the rising prevalence of cardiovascular diseases. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart or blood vessels, typically impacting the circulatory system. An increase in cardiovascular diseases leads to a larger patient population requiring treatment for arterial occlusions and atherosclerotic plaque, consequently boosting the demand for laser atherectomy devices. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the growing incidence of cardiovascular diseases is a significant factor propelling the growth of the laser atherectomy devices market.

    How Are Segments Identified Within The Laser Atherectomy Devices Market Segment Framework?

    The laser atherectomy devices market covered in this report is segmented –

    1) By Type: Excimer Laser Atherectomy Devices, Solid-State Laser Atherectomy Devices, Ultraviolet (UV) Laser Atherectomy Devices, Infrared (IR) Laser Atherectomy Devices

    2) By Application: Cardiovascular, Peripheral Vascular, Neurovascular

    3) By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users

    Subsegments:

    1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems, Peripheral Excimer Laser Systems, In-Stent Restenosis (ISR) Laser Systems

    2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems, Holmium:YAG Laser Atherectomy Systems, Diode-Based Laser Atherectomy Systems

    3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems, Continuous-Wave UV Laser Atherectomy Systems

    4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems, Mid-Infrared Laser Atherectomy Systems

    Which Trends Are Expected To Impact The Laser Atherectomy Devices Market?

    Leading companies in the laser atherectomy devices market are developing advanced solutions, such as atherectomy platforms, to broaden their customer base, increase sales, and boost revenue. An atherectomy platform is a comprehensive system or collection of tools designed for the treatment of atherosclerosis, a medical condition characterized by plaque accumulation in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance for its FreedomFlow, an orbital atherectomy peripheral platform. The unique aspect of the FreedomFlow platform is its modern mechanism of action, specifically engineered for clearing plaque blockages in leg arteries. This proprietary, catheter-based design applies angular momentum physics to create a spiral geometry, ensuring continuous contact with the vessel wall during both advancement and retraction, by incorporating five diamond-coated spheres. Additionally, a diamond-coated tip helps the driveshaft pass smoothly through constricted blockages. This innovative methodology offers physicians an exceptionally efficient, effective, and flexible way to treat complex Peripheral Artery Disease (PAD) across a wide range of vessel diameters, spanning from 2 mm in the ankle to 8 mm in the hip. The platform provides increased adaptability for addressing multiple arteries and numerous blockages within the same vessel, all accomplished with a single device.

    Who Are The Companies Competing Within The Laser Atherectomy Devices Market?

    Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc

    Get The Full Laser Atherectomy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Which Region Is The Leading Market For The Laser Atherectomy Devices Market?

    North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Laser Atherectomy Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

    Browse Through More Reports Similar to the Global Laser Atherectomy Devices Market 2026, By The Business Research Company

    Atherectomy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

    Ophthalmic Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/ophthalmic-medical-lasers-global-market-report

    Medical Lasers Market Report 2026

    https://www.thebusinessresearchcompany.com/report/medical-lasers-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Coronary Artery Disease Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    Coronary Artery Disease Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Value Is Expected For The Coronary Artery Disease Market At The End Of The 2026–2030 Forecast Period?

    The market size for coronary artery disease has expanded swiftly in recent years. It is anticipated to increase from $31.88 billion in 2025 to $35.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. This historic period’s growth can be linked to the high prevalence of cardiovascular disease, sedentary lifestyles, tobacco consumption, limited preventive care awareness, and hospital-centric treatment models.

    The market size for coronary artery disease is anticipated to undergo substantial growth in the upcoming years. This market is set to expand to $53.97 billion by 2030, with a compound annual growth rate (CAGR) of 11.2%. The expansion during this forecast period is attributable to a burgeoning global elderly population, escalating rates of obesity, enhanced diagnostic technologies, the advancement of preventive cardiology, and greater access to healthcare. Significant developments expected in the forecast period encompass a heightened emphasis on early disease detection, the increasing application of combination drug therapies, the proliferation of lifestyle modification programs, the broader availability of minimally invasive treatments, and the integration of cardiac rehabilitation services.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Coronary Artery Disease Market?

    The increasing incidence of coronary artery disease is anticipated to drive expansion in the coronary artery disease market in the forthcoming years. Coronary artery disease (CAD) defines a health condition marked by the constriction or obstruction of the coronary arteries, vital for supplying blood to the heart muscle. The growing number of coronary artery disease cases stems from evolving dietary habits, heightened stress levels, insufficient physical activity, obesity, advancing age, among other factors. Treatment for coronary artery disease involves medications such as clopidogrel, ticagrelor, warfarin, and heparin, alongside procedures like coronary artery bypass grafting, angioplasty, and stenting. As an illustration, in October 2025, data from the Australian Institute of Health and Welfare, an Australian government body, indicated that in 2023, approximately 2,700 acute coronary events affected First Nations people aged 25 and older. When accounting for population age structure, this incidence rate was 2.8 times greater compared to non-Indigenous people. Consequently, the growing prevalence of coronary artery disease is projected to stimulate the coronary artery disease market throughout the forecast period.

    What Segment Types Make Up The Coronary Artery Disease Market?

    The coronary artery disease market covered in this report is segmented –

    1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments

    2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

    4) By End-User: Hospitals, Specialty Clinics, Other End-Users

    Subsegments:

    1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors

    2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery

    3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies

    4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices

    How Are Trends Shaping The Direction Of The Coronary Artery Disease Market?

    Leading companies operating within the coronary artery disease market are concentrating on developing innovative products, such as drug-coated balloon catheters, to expand their market revenues. Drug-coated balloon catheters are medical devices employed in interventional cardiology to address narrowed or blocked blood vessels, particularly in the context of coronary artery disease or peripheral artery disease. For instance, in March 2024, Boston Scientific Corporation, a US-based medical device company, announced the US Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), indicated for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR describes the obstruction or narrowing of a stented vessel due to plaque or scar tissue. The AGENT DCB presents a specialized treatment option for the challenging condition of in-stent restenosis (ISR), thereby addressing a significant unmet medical need. It is specifically engineered for treating ISR, in addition to previously untreated small vessel coronary disease. Available in Europe, parts of Asia Pacific, and Latin America, the AGENT DCB delivers a targeted solution for these complex cardiovascular conditions.

    Who Are The Key Players Driving Competition In The Coronary Artery Disease Market?

    Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.

    Read the full coronary artery disease market report here:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    How Is The Coronary Artery Disease Market Distributed Across Key Geographic Regions?

    North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Coronary Artery Disease Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

    Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company

    Coronary Artery Disease Global Market Report

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Aortic Stent Grafts Global Market Report

    https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report

    Heart Transplant Global Market Report

    https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model